These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16997689)

  • 1. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Mann J
    Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Walsh M; Fromm G
    Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolysis in stroke: still not ready for community hospital use by emergency physicians.
    McNamara RM
    Ann Emerg Med; 2009 Sep; 54(3):339-41. PubMed ID: 19695417
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hundred (and one) graphs tell only part of the story.
    Silbergleit R
    Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418
    [No Abstract]   [Full Text] [Related]  

  • 6. Stroking the data: re-analysis of the NINDS trial.
    Magid D; Naviaux N; Wears RL
    Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alteplase treatment for acute stroke 2007: an effective therapeutic option at our disposal].
    Carneado-Ruiz J; Saver JL
    Rev Neurol; 2007 Jul 1-15; 45(1):42-52. PubMed ID: 17620265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute stroke management.
    Ducharme J; Currie T; Ovens H; Rutledge T; Thompson J
    Can Fam Physician; 2001 Dec; 47():2458. PubMed ID: 11785275
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
    Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
    Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to "A graphic reanalysis of the NINDS Trial".
    Dewey HM; Churilov L; Blacker D; Bladin C; Davis SM; Donnan GA; Gates P; Gerraty RP; Hand P; Levi C; Lindley RI; Markus R; Read S
    Ann Emerg Med; 2010 Feb; 55(2):227-9; author reply 229. PubMed ID: 20116035
    [No Abstract]   [Full Text] [Related]  

  • 12. Early management of stroke patients in the emergency department.
    Woloszyn AV; Schwarz MA
    J Pharm Pract; 2011 Apr; 24(2):160-73. PubMed ID: 21712211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
    Finnigan SP; Rose SE; Chalk JB
    Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 15. Thinking globally, acting locally.
    Wears RL; Magid DJ
    Ann Emerg Med; 2005 Jul; 46(1):61-3. PubMed ID: 15988428
    [No Abstract]   [Full Text] [Related]  

  • 16. Agreement with evidence for tissue Plasminogen Activator use among emergency physicians: a cross-sectional survey.
    Grady AM; Bryant J; Carey ML; Paul CL; Sanson-Fisher RW; Levi CR
    BMC Res Notes; 2015 Jun; 8():267. PubMed ID: 26111807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of tissue plasminogen activator to treat acute ischemic stroke.
    Alexandrov AW
    Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk adjustment effect on stroke clinical trials.
    Johnston KC; Connors AF; Wagner DP; Haley EC
    Stroke; 2004 Feb; 35(2):e43-5. PubMed ID: 14715975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
    Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
    J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NINDS Reanalysis Committee's reanalysis of the NINDS trial.
    Mann J
    Stroke; 2005 Feb; 36(2):230-1; author reply 230-1. PubMed ID: 15637327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.